Logo image
Gold Nanoparticles Enhancing Generation of ROS for Cs-137 Radiotherapy
期刊文章   開放取用(OA)   同儕審查

Gold Nanoparticles Enhancing Generation of ROS for Cs-137 Radiotherapy

Shiao-Wen Tsai, Chang-Yun Lo, Shang-Yang Yu, Fang-Hsin Chen, Hsiao-Chieh Huang, Lu-Kai WangJiunn-Woei Liaw
Nanoscale Research Letters, 卷.17(1), 123
2022

摘要

Amplification factor Cs-137 Disruption of cytoskeleton Gold nanoparticles Mitochondrial damage Radiosensitization enhancement factor Radiosensitizer Radiotherapy Reactive oxygen species Tumoricidal efficacy Materials Science (all) Condensed Matter Physics
Radiotherapy is an important modality for the treatment of cancer, e.g., X-ray, Cs-137 γ-ray (peak energy: 662 keV). An important therapy pathway of radiation is to generate the double strand breaks of DNA to prohibit the proliferation of cancer cells. In addition, the excessive amount of reactive oxygen species (ROS) is induced to damage the organelles, which can cause cellular apoptosis or necrosis. Gold nanoparticles (GNPs) have been proven potential as a radiosensitizer due to the high biocompatibility, the low cytotoxicity and the high-Z property (Z = 79) of gold. The latter property may allow GNPs to induce more secondary electrons for generating ROS in cells as irradiated by high-energy photons. In this paper, the radiobiological effects on A431 cells with uptake of 55-nm GNPs were studied to investigate the GNPs-enhanced production of ROS on these cells as irradiated by Cs-137 γ-ray. The fluorescence-labeling image of laser scanning confocal microscopy (LSCM) shows the excessive expression of ROS in these GNPs-uptake cells after irradiation. And then, the follow-up disruption of cytoskeletons and dysfunction of mitochondria caused by the induced ROS are observed. From the curves of cell survival fraction versus the radiation dose, the radiosensitization enhancement factor of GNPs is 1.29 at a survival fraction of 30%. This demonstrates that the tumoricidal efficacy of Cs-137 radiation can be significantly raised by GNPs. Because of facilitating the production of excessive ROS to damage tumor cells, GNPs are proven to be a prospective radiosensitizer for radiotherapy, particularly for the treatment of certain radioresistant tumor cells. Through this pathway, the tumoricidal efficacy of radiotherapy can be raised.

檔案與連結 (1)

url
https://doi.org/10.1186/s11671-022-03761-w檢視
已出版(紀錄版本) 開放

相關連結

指標

1 檢視次數

詳細資料

Logo image